Do you want to read an article? Please log in or register.
Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant
COVID-19
Related content
COVID-19
Association of the Delta (B.1.617.2) Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) With Pregnancy Outcomes
Obstet Gynecol
Wang AM, Berry M, Moutos CP, Omere C, Clark SM, Harirah HM, Jain S, Olson GL, Pacheco LD, Saade GR, Saad AF
doi: 10.1097/AOG.0000000000004595
RECOMMENDED
COVID-19
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur J Cancer
Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C
doi: 10.1016/j.ejca.2021.10.014
COVID-19Cardiovascular
COVID-19 et maladies cardiovasculaires : une association à double sens
healthbook TIMES
COVID-19
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus
Ann Rheum Dis
Moyon Q, Sterlin D, Miyara M, Anna F, Mathian A, Lhote R, Ghillani-Dalbin P, Breillat P, Mudumba S, de Alba S, Cohen-Aubart F, Haroche J, Pha M, Boutin THD, Chaieb H, Flores PM, Charneau P, Gorochov G, Amoura Z
doi: 10.1136/annrheumdis-2021-221097
COVID-19
Pandémie de COVID-19 : un défi et une chance pour la santé mentale de la population
healthbook TIMES
COVID-19
Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients
Mult Scler
Georgieva ZG, Dӧffinger R, Kumararatne D, Coles AJ, McCarthy C
doi: 10.1177/13524585211046786
COVID-19
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities
Clin Res Cardiol
Rieder M, Gauchel N, Kaier K, Jakob C, Borgmann S, Classen AY, Schneider J, Eberwein L, Lablans M, Rüthrich M, Dolff S, Wille K, Haselberger M, Heuzeroth H, Bode C, von Zur Mühlen C, Rieg S, Duerschmied D
doi: 10.1007/s00392-021-01939-3
RECOMMENDED
COVID-19
STudy of Alteplase for Respiratory failure in SARS-Cov2 COVID-19 (STARS): A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized, Controlled Trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Chest
Barrett CD, Moore HB, Moore EE, Wang DJ, Hajizadeh N, Biffl WL, Lottenberg L, Patel PR, Truitt MS, McIntyre R, Bull TM, Ammons LA, Ghasabyan A, Chandler J, Douglas I, Schmidt E, Moore PK, Wright FL, Ramdeo R, Borrego R, Rueda M, Dhupa A, McCaul DS, Dandan T, Sarkar PK, Khan B, Sreevidya C, McDaniel C, Grossman Verner HM, Pearcy C, Anez-Bustillos L, Baedorf-Kassis EN, Jhunjhunwala R, Shaefi S, Capers K, Banner-Goodspeed V, Talmor DS, Sauaia A, Yaffe MB
doi: 10.1016/j.chest.2021.09.024
COMMENTED
COVID-19
Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care
Wander PL, Lowy E, Beste LA, Tulloch-Palomino L, Korpak A, Peterson AC, Kahn SE, Boyko EJ
doi: 10.2337/dc21-1351